Should we use β‑blockers for myocardial infarction?

Should we use β‑blockers for myocardial infarction?

Cardiac markers for acute myocardial infarction: when should we test?

Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.

ow quickly time flies! It has now been a decade since eporting the first randomized trial of coronary stenting for cute myocardial infarction (AMI). At that time, it was hocking to think that one could place a metal foreign body nto a thrombogenic milieu and expect the artery to remain atent. Hence, we and others conducted several randomized rials comparing primary angioplasty and stenting, and...

Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?

BACKGROUND Clinical trials concerning acute myocardial infarction often evaluate short-term death. Several baseline characteristics are predictors of death, most notably age. Adjustment for one or more predictors in a multivariable analysis may be considered to correct the estimate of the treatment effect for any imbalance that by chance may have occurred between the randomized groups. Moreover...

Should we consider serum potassium level as a mortality predictor in ST-elevation myocardial infarction?

I read the article by Uluganyan et al. (1) entitled “Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction” with great interest, which was published online in your Anatol J Cardiol 2015 Febr 11. In their study, the authors reported that the admission serum potassium (sK) level of >4.5 mmol/L was associated with increased lon...